FDA clears new software for mitral valve repair | AI-powered CCTA assessments vs. IVUS | Safety in the cath lab

Philips worked closely with Edwards Lifesciences to develop the new software.

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

However, the regular supply of these imaging radiotracers may not be back online for another few months.

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature. 

The new SmartHeart technology automates 14 cardiac views in less than 30 seconds. It was designed to increase productivity and bring more consistency to cardiology and radiology departments.

Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.

Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations.